…
L'Air Liquide S.A. provides gases, technologies, and services for the industrial and health sectors in Europe, the Americas, the Asia Pacific, the Middle East, and Africa. It operates in Gas & Services, and Engineering & Construction segments. The Gas & Services segment comprises large industries business, which offers gas and energy solutions including oxygen, nitrogen, argon, hydrogen, and carbon monoxide, as well as operates cogeneration plants to supply steam and electricity to metals, chemicals, refining, and energy industries; and industrial merchant business line provides industrial gases, equipment, hardgoods, and associated services to materials and energy, materials and chemicals, food and pharmaceuticals, technology and research, and fabrication and construction sectors. This segment also includes healthcare business, which provides medical gases, home healthcare services, medical equipment, and specialty ingredient; healthcare professionals, and hospitals; and electronic business supply carrier gases, electronic specialty and advanced materials, equipment and installation, service, and analysis to semiconductor, flat panel, and photovoltaic markets. The Engineering & Construction segment designs, develops, and builds industrial gas production plants to third parties; and designs and manufacture plants in the traditional, renewable, and alternative energy sectors. This segment also focuses on markets which require a global approach, drawing on science, technologies, development models, and usages related to digital transformation. L'Air Liquide S.A. was incorporated in 1902 and is headquartered in Paris, France.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Air Liquide SA supplies industrial, medical and specialty gases and related services through a global production and distribution network. Long-term growth may be driven by demand for low‑carbon hydrogen, healthcare services, semiconductor gases and recurring industrial contracts. Investors may find it attractive because it appears positioned with scale, diversified end markets and contract visibility that could support stable cash flow.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 4682.50M | 4527.20M | 4160.20M | 3905.10M | 3601.30M |
| Minority interest | -126.50M | -133.90M | -110.40M | -145.10M | -119.70M |
| Net income | 3379.06M | 3306.10M | 3078.00M | 2758.80M | 2572.20M |
| Gross profit | 9256.75M | 17049.60M | 16460.80M | 16121.00M | 13946.10M |
| Reconciled depreciation | 2563.50M | 2505.10M | 2482.00M | 2465.90M | 2172.50M |
| Ebit | 5361.31M | 4785.60M | 4228.40M | 4291.10M | 4009.60M |
| Ebitda | 7823.63M | 7290.70M | 6710.40M | 7307.90M | 6258.40M |
| Depreciation and amortization | 2462.33M | 2505.10M | 2482.00M | 3016.80M | 2248.80M |
| Operating income | 5361.31M | 4945.60M | 4571.50M | 4291.10M | 4009.60M |
| Other operating expenses | 20515.63M | 22112.20M | 23036.10M | 25072.20M | 19174.50M |
| Interest expense | 388.06M | 258.40M | 503.69M | 366.20M | 333.90M |
| Tax provision | 1230.50M | 1086.50M | 971.80M | 1002.30M | 914.80M |
| Interest income | 69.00M | 75.00M | 69.40M | 33.00M | 12.20M |
| Net interest income | -396.20M | -418.40M | -416.20M | -386.00M | -408.30M |
| Income tax expense | 1181.94M | 1086.50M | 971.80M | 1002.30M | 914.80M |
| Total revenue | 25876.94M | 27057.80M | 27607.60M | 29934.00M | 23334.80M |
| Total operating expenses | 3895.44M | 12104.00M | 11889.30M | 11259.20M | 9785.80M |
| Cost of revenue | 16620.19M | 10008.20M | 11146.80M | 13813.00M | 9388.70M |
| Total other income expense net | -678.81M | -418.40M | -411.30M | -386.00M | -408.30M |
| Net income from continuing ops | 3644.40M | 3440.00M | 3188.40M | 2903.90M | 2691.90M |
| Net income applicable to common shares | - | - | - | 2758.80M | 2572.20M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 51891.31M | 51867.50M | 48332.40M | 49518.00M | 46783.10M |
| Intangible assets | 1561.63M | 1691.50M | 1631.30M | 1811.40M | 1452.60M |
| Other current assets | 999.37M | 1245.80M | 1138.80M | 632.10M | 524.00M |
| Total liab | 24955.57M | 24246.20M | 23289.30M | 24946.00M | 24784.30M |
| Total stockholder equity | 26202.74M | 26860.00M | 24321.50M | 23736.40M | 21462.30M |
| Other current liab | 3179.65M | 2980.80M | 2706.90M | 2883.40M | 375.50M |
| Common stock | 3185.24M | 3180.40M | 2884.80M | 2879.00M | 2614.10M |
| Capital stock | 3186.60M | 3180.40M | 2884.80M | 2879.00M | 2614.10M |
| Retained earnings | 21005.46M | 21840.30M | 20495.40M | 18626.80M | 16217.30M |
| Other liab | - | - | - | 4799.90M | 4792.60M |
| Good will | 13817.32M | 14977.40M | 14194.20M | 14587.20M | 13992.30M |
| Other assets | - | - | -95.10M | 631.60M | 665.20M |
| Cash | 3960.31M | 1915.30M | 1478.90M | 1756.40M | 2096.60M |
| Total current liabilities | 8753.97M | 9484.10M | 8846.00M | 8896.20M | 8444.50M |
| Current deferred revenue | - | - | 630.90M | - | 2321.70M |
| Net debt | 10704.64M | 10532.80M | 10558.70M | 11619.30M | 11784.00M |
| Short term debt | 2571.51M | 2911.20M | 2464.80M | 2230.20M | 2414.10M |
| Short long term debt | 2347.50M | 2671.40M | 2245.10M | 2002.60M | 2186.10M |
| Short long term debt total | 14664.96M | 12448.10M | 12037.60M | 13375.70M | 13880.60M |
| Other stockholder equity | 2012.04M | 1839.30M | 941.30M | 2230.60M | 2630.90M |
| Property plant equipment | - | - | - | 23646.90M | 22531.50M |
| Total current assets | 9985.15M | 8347.40M | 7717.60M | 8238.20M | 7590.60M |
| Net tangible assets | - | - | - | 7337.80M | 6017.40M |
| Short term investments | - | - | 1.20M | - | - |
| Net receivables | 2898.07M | 2996.70M | 2993.70M | 3888.70M | 3384.90M |
| Long term debt | 10030.00M | 8403.10M | 8526.50M | 10093.30M | 10433.70M |
| Inventory | 2127.39M | 2189.60M | 2027.60M | 1961.00M | 1585.10M |
| Accounts payable | 3002.82M | 3319.00M | 2807.00M | 3782.60M | 3333.20M |
| Accumulated other comprehensive income | - | -432.20M | -1353.70M | - | - |
| Non currrent assets other | 380.04M | 455.10M | 718.10M | 1002.00M | 976.80M |
| Non current assets total | 41906.16M | 43520.10M | 40709.90M | 41279.80M | 39192.50M |
| Capital lease obligations | 1259.40M | 1373.60M | 1266.00M | 1279.80M | 1260.80M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -3583.40M | -3079.00M | -3241.90M | -3351.50M |
| Change to liabilities | - | - | - | 0.00M | 0.00M |
| Total cashflows from investing activities | -3642.15M | -3583.40M | -3079.00M | -3241.90M | -3351.50M |
| Net borrowings | 2060.40M | -266.80M | -1215.60M | -866.70M | -258.60M |
| Total cash from financing activities | -134.76M | -2807.60M | -3479.70M | -2781.00M | -1815.70M |
| Change to operating activities | - | - | - | -396.80M | 377.30M |
| Net income | 3379.06M | 3306.10M | 3078.00M | 2758.80M | 2572.20M |
| Change in cash | 2272.33M | -101.20M | -357.30M | -378.00M | 420.30M |
| Begin period cash flow | 1687.98M | 1403.60M | 1760.90M | 2138.90M | 1718.60M |
| End period cash flow | 3960.31M | 1302.40M | 1403.60M | 1760.90M | 2138.90M |
| Total cash from operating activities | 6103.99M | 6322.20M | 6263.00M | 5810.10M | 5570.70M |
| Issuance of capital stock | 139.50M | 34.40M | 128.80M | 37.70M | 175.40M |
| Depreciation | 2462.33M | 2505.10M | 2482.00M | 2465.90M | 2172.50M |
| Other cashflows from investing activities | - | 97.70M | -262.00M | 13.80M | 5.50M |
| Dividends paid | 1877.84M | 1718.10M | 1581.20M | -1410.50M | -1334.80M |
| Change to inventory | - | -145.50M | - | - | - |
| Sale purchase of stock | -3.84M | -230.80M | -81.90M | -191.50M | -40.10M |
| Other cashflows from financing activities | -366.16M | -626.30M | -729.80M | -1216.70M | -36.80M |
| Change to netincome | - | - | - | 982.20M | 448.70M |
| Capital expenditures | 3691.71M | 3525.10M | 3393.40M | 3273.00M | 2916.80M |
| Change in working capital | -217.08M | 148.90M | 257.00M | 261.70M | 447.50M |
| Stock based compensation | - | - | 39.60M | - | - |
| Other non cash items | 374.70M | 362.10M | 446.00M | 323.70M | 378.50M |
| Free cash flow | 2412.28M | 2797.10M | 2869.60M | 2537.10M | 2653.90M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AIQUY Air Liquide SA ADR |
-0.21 0.54% |
38.89 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| LIN Linde plc Ordinary Shares |
1.09 0.21% |
508.65 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUF L'Air Liquide S.A |
-0.00 0.00% |
196.44 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
-9.15 2.73% |
326.01 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
| ECL Ecolab Inc |
2.38 0.82% |
291.27 | 37.06 | 29.59 | 4.57 | 7.68 | 5.11 | 21.59 |
L'Air Liquide S.A. provides gases, technologies, and services for the industrial and health sectors in Europe, the Americas, the Asia Pacific, the Middle East, and Africa. It operates in Gas & Services, and Engineering & Construction segments. The Gas & Services segment comprises large industries business, which offers gas and energy solutions including oxygen, nitrogen, argon, hydrogen, and carbon monoxide, as well as operates cogeneration plants to supply steam and electricity to metals, chemicals, refining, and energy industries; and industrial merchant business line provides industrial gases, equipment, hardgoods, and associated services to materials and energy, materials and chemicals, food and pharmaceuticals, technology and research, and fabrication and construction sectors. This segment also includes healthcare business, which provides medical gases, home healthcare services, medical equipment, and specialty ingredient; healthcare professionals, and hospitals; and electronic business supply carrier gases, electronic specialty and advanced materials, equipment and installation, service, and analysis to semiconductor, flat panel, and photovoltaic markets. The Engineering & Construction segment designs, develops, and builds industrial gas production plants to third parties; and designs and manufacture plants in the traditional, renewable, and alternative energy sectors. This segment also focuses on markets which require a global approach, drawing on science, technologies, development models, and usages related to digital transformation. L'Air Liquide S.A. was incorporated in 1902 and is headquartered in Paris, France.
| Name | Title | Year Born |
|---|---|---|
| Mr. Francois Jackow | Exec. VP, CEO & Director | 1969 |
| Mr. Jérôme Pelletan | Chief Financial Officer | 1970 |
| Christiane Muller | VP of Global Markets & Technologies Activities | NA |
| Aude Rodriguez | Head of Investor Relations | NA |
| Ms. Armelle Levieux | VP of Group HR | 1973 |
| Mr. Jean-Marc de Royere | Sr. VP | 1965 |
| Mr. Michael J. Graff | Exec. VP | 1955 |
| Ms. Fabienne Lecorvaisier | Exec. VP | 1962 |
| Mr. Pascal Vinet | Sr. VP | 1962 |
| Mr. François Abrial | Sr. VP | 1962 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.